Personalized medicine has the potential to drive practice-changing medicine for indications
ranging from oncology to transplantation and beyond. Conventionally, the field of medicine …

IDentif. AI-x, a clinically actionable artificial intelligence platform, was used to rapidly
pinpoint and prioritize optimal combination therapies against COVID-19 by pairing a …

Worldwide, digital medicine technologies are being developed at a rapid rate. While these
digital medicine technologies offer the potential to transform and revolutionize health care …

Background: Current standard of care (SOC) regimens against nontuberculous
mycobacteria (NTM) usually result in unsatisfactory therapeutic responses, primarily due to …

The substantial increase in global population and climate change, among other factors,
have led to global food security and supply chain challenges. The United Nations has laid …

COVID-19 drug development has largely focused on repurposing, either through single
agent or combination therapy 1–5. To date, clinical trial outcomes of the repurposed …

Biomarkers are a key tool in medicine, especially in the domain of personalized medicine.
They are valuable for the early detection, prognosis, and diagnosis of disease as well as for …

Conventional training often uses fixed-intensity programs which can lead to plateaus in
learning trajectories and sub-optimal outcomes. Hence, individualized programs are …